Bio Medica Lab

Why is Bio Medica Laboratories Ltd falling/rising?

As of 26-Aug, Bio Medica Laboratories Ltd's stock price is at 153.40, down 0.07%, underperforming the market and its sector due to a significant drop in investor participation and trading activity. Despite trading above longer-term moving averages, it is below its 5-day moving average, indicating short-term weakness.

As of 26-Aug, Bio Medica Laboratories Ltd's stock price is currently at 153.40, reflecting a slight decrease of 0.1, or 0.07%. This decline is indicative of the stock underperforming compared to the broader market, as it has fallen by 3.73% over the past week while the Sensex has gained 0.54%. <BR><BR>Additionally, the stock's performance today has underperformed its sector by 0.36%. A significant factor contributing to this downward trend is the notable drop in investor participation, with delivery volume on 25 August falling by 93.56% compared to the 5-day average. This sharp decline in trading activity suggests reduced investor interest, which can negatively impact stock prices.<BR><BR>While the stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, it is below its 5-day moving average, indicating a short-term weakness. Overall, these factors collectively contribute to the stock's current decline.

Which are the latest news on Bio Medica Lab?

What does Bio Medica Lab do?

Bio Medica Laboratories Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2015. It has a market cap of INR 186 Cr, with a P/E ratio of 16.00 and a return on equity of 79.21%.

Overview:<BR>Bio Medica Laboratories Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Bio Medica Laboratories Ltd was originally incorporated as a private limited company under the name "Bio Medica Laboratories Private Limited" on August 14, 2015. There are no reported changes in status, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 186 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00<BR>Industry P/E: 37<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 1.02<BR>Return on Equity: 79.21%<BR>Price-to-Book: 12.38<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Bio Medica Lab?

Bio Medica Lab's peers include Nectar Lifesci, Brooks Lab, Sat Kartar Life, and others. Management risk varies from excellent at Sat Kartar Life to below average at several others, with Nectar Lifesci showing the highest negative 1-year return at -25.54%.

Peers: The peers of Bio Medica Lab are Nectar Lifesci., Brooks Lab., Sat Kartar Life, Natural Capsules, Achyut Healthcar, Kerala Ayurveda, Coral Labs., Panch.Organics, and Syschem (India).<BR><BR>Quality Snapshot: Excellent management risk is observed at Sat Kartar Life, while Average management risk is found at Nectar Lifesci. and Panch.Organics, and the rest. Below Average management risk is noted at Brooks Lab., Natural Capsules, Achyut Healthcar, Kerala Ayurveda, Coral Labs., and Syschem (India). For Growth, Excellent growth is seen at Sat Kartar Life, while Below Average growth is found at Nectar Lifesci., Brooks Lab., Natural Capsules, and the rest. Average growth is noted at Achyut Healthcar, while Good growth is observed at Syschem (India). Below Average capital structure is present at Nectar Lifesci., Brooks Lab., Natural Capsules, Kerala Ayurveda, and the rest, while Good capital structure is noted at Achyut Healthcar and Syschem (India), and Excellent capital structure is seen at Coral Labs. and Panch.Organics.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Nectar Lifesci. at -25.54%, while Brooks Lab. has the lowest at -58.01%. Bio Medica Lab's 1-year return is not available for comparison. Additionally, peers with a negative six-month return include Nectar Lifesci., Brooks Lab., Natural Capsules, and Kerala Ayurveda.

How big is Bio Medica Lab?

As of 14th August, Bio Medica Laboratories Ltd has a market capitalization of 184.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 14.73 Cr and Total Assets of 38.90 Cr.

As of 14th August, <BR><BR>Market Cap: Bio Medica Laboratories Ltd has a market capitalization of 184.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 14.73 Cr and Total Assets valued at 38.90 Cr.